p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-up

Eur Urol Oncol. 2023 Feb;6(1):110-112. doi: 10.1016/j.euo.2021.12.003. Epub 2021 Dec 27.

¹ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
³ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
⁴ Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: tlotan1@jhmi.edu.

No abstract available

Publication types